Active specific immunotherapy with an autologous virus-modified tumour cell vaccine in human renal cell carcinoma (RCC)
D002292:Carcinoma, Renal Cell / Q000628:therapy*; D005260:Female; D006801:Humans; D016233:Immunotherapy, Active; D007680:Kidney Neoplasms / Q000628:therapy*; D008297:Male; D011446:Prospective Studies; D015996:Survival Rate